C16orf46 divergent transcript (C16orf46-DT)

C16orf46 divergent transcript (C16orf46-DT), also known as lnc-ATMIN-4:2, is a long non-coding RNA (lncRNA) gene found on chromosome 16[5][1]. It does not encode a protein and is not classified as a receptor, enzyme, or other classical therapeutic target[5][1]. There is no evidence that it has a defined biological function, serves as a direct disease biomarker, or is currently implicated in drug targeting or human disease. The "divergent transcript" designation refers to the arrangement of the gene in the genome, typically transcribed in the opposite direction from a nearby (often protein-coding) gene[4]. This class of lncRNAs is hypothesized to play roles in gene regulatory and chromatin-related processes, but specific functions and clinical relevance of C16orf46-DT remain largely unknown[5][4]. There is no indication that C16orf46-DT is misspelled, but there is insufficient evidence for it being a relevant therapeutic target or biomarker, so it should not be classified as such[5][1].

Other names

lnc-ATMIN-4:2